EXCLUSIVE: Survodutide shows potential to predominantly target visceral fat, its Chief Executive Shashank Deshpande said in an interview.
Source link
About The Author
Boehringer Ingelheim’s Obesity Drug Helps Lose Fat Rather Than Muscle, Late-Stage Trial Shows